Authors
Loading...
Randomized trial reveals modulation of Alzheimer's disease signatures in 3×Tg-AD mice, suggesting new treatment potential.
Gezginer et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: